Airway Medix S.A. (AWM.WA)
PLN 0.28
(3.33%)
PLN 0.28
(3.33%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -166 Thousand PLN | 6.48% |
| 2022 | -35.52 Million PLN | -117.23% |
| 2021 | -9.14 Million PLN | 1792.52% |
| 2020 | -1.23 Million PLN | 39.74% |
| 2019 | -1.68 Million PLN | -61.65% |
| 2018 | -1.83 Million PLN | -200.0% |
| 2017 | -4.24 Million PLN | 140.38% |
| 2016 | -2.58 Million PLN | -112.59% |
| 2015 | -1.21 Million PLN | -11.67% |
| 2014 | -1.08 Million PLN | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -1.61 Million PLN | -357.09% |
| 2024 Q2 | -841 Thousand PLN | 36.48% |
| 2023 Q2 | 170 Thousand PLN | 126.86% |
| 2023 FY | - PLN | 6.48% |
| 2023 Q1 | -633 Thousand PLN | -162.61% |
| 2023 Q4 | -1.17 Million PLN | -115.93% |
| 2023 Q3 | -546 Thousand PLN | -421.18% |
| 2022 FY | - PLN | -117.23% |
| 2022 Q3 | -264 Thousand PLN | 84.3% |
| 2022 Q4 | 1.01 Million PLN | 482.95% |
| 2022 Q2 | -1.68 Million PLN | -351.88% |
| 2022 Q1 | -372 Thousand PLN | -102.04% |
| 2021 Q3 | -269 Thousand PLN | 27.88% |
| 2021 FY | - PLN | 1792.52% |
| 2021 Q2 | -373 Thousand PLN | -244.57% |
| 2021 Q1 | 258 Thousand PLN | -87.28% |
| 2021 Q4 | 18.2 Million PLN | 6867.29% |
| 2020 FY | - PLN | 39.74% |
| 2020 Q3 | 11 Thousand PLN | 100.63% |
| 2020 Q2 | -1.75 Million PLN | -2984.21% |
| 2020 Q4 | 2.02 Million PLN | 18345.45% |
| 2020 Q1 | -57 Thousand PLN | 64.81% |
| 2019 Q4 | -162 Thousand PLN | -176.06% |
| 2019 Q1 | 71 Thousand PLN | -94.19% |
| 2019 Q2 | -601 Thousand PLN | -946.48% |
| 2019 Q3 | 213 Thousand PLN | 135.44% |
| 2019 FY | - PLN | -61.65% |
| 2018 FY | - PLN | -200.0% |
| 2018 Q4 | 1.22 Million PLN | 161.81% |
| 2018 Q3 | -1.97 Million PLN | -669.74% |
| 2018 Q2 | 347 Thousand PLN | 241.63% |
| 2018 Q1 | -245 Thousand PLN | -110.29% |
| 2017 Q1 | -678 Thousand PLN | -17.5% |
| 2017 Q2 | -163 Thousand PLN | 75.96% |
| 2017 FY | - PLN | 140.38% |
| 2017 Q3 | -554 Thousand PLN | -239.88% |
| 2017 Q4 | 2.38 Million PLN | 529.6% |
| 2016 Q1 | -328 Thousand PLN | 62.08% |
| 2016 FY | - PLN | -112.59% |
| 2016 Q4 | -577 Thousand PLN | 19.19% |
| 2016 Q3 | -714 Thousand PLN | 27.66% |
| 2016 Q2 | -987 Thousand PLN | -200.91% |
| 2015 Q1 | -204.2 Thousand PLN | -127.05% |
| 2015 FY | - PLN | -11.67% |
| 2015 Q3 | -119 Thousand PLN | -41.67% |
| 2015 Q2 | -84 Thousand PLN | 58.86% |
| 2015 Q4 | -865 Thousand PLN | -626.89% |
| 2014 FY | - PLN | 0.0% |
| 2014 Q3 | -348 Thousand PLN | -357.89% |
| 2014 Q4 | 754.93 Thousand PLN | 316.94% |
| 2014 Q2 | -76 Thousand PLN | 82.55% |
| 2014 Q1 | -435.41 Thousand PLN | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Mercator Medical S.A. | 19.42 Million PLN | 100.854% |